The volume of imports of medicines to Russia from the European Union and the United States is still at the level of last year, the head of the Federal Customs Service (FCS) Vladimir Bulavin told RIA Novosti.
“So far, the volume of imports of medicines from the European Union and the United States remains at last year’s level. This is because medicines are not under sanctions. In April, 4.7 thousand tons of medicines and medical products were declared,” Bulavin said.
According to him, the suppliers of the leading medicines to the Russian Federation are Germany, France, India, Belarus, and the UK. “The most expensive medicines come to us from the US, Ireland, Switzerland, and Canada,” he added.
Foreign states did not impose sanctions on the supply of medicines to Russia. However, due to the events in Ukraine and the logistical difficulties that arose against their background, many pharmaceutical companies somehow changed their presence on the Russian market. Thus, the French Sanofi has stopped new supplies not related to vital drugs and vaccines. The Japanese Takeda Pharmaceutical Company temporarily refused to conduct further clinical trials in Russia and new investments. The German company Bayer, in turn, said it would suspend advertising and investment in Russia but continue to supply medicines.
At the same time, medical equipment manufacturers Philips and General Electric said they were staying in Russia. Siemens was about to stop the export of medical equipment but later said that it would continue to support medical service providers.